Wegovy Prices in the UK: What Affects the Cost

The cost of Wegovy (semaglutide) in the UK depends mainly on how you access it, which dose you take, and how a private provider structures its fees. On the NHS, Wegovy is available only through specialist weight management services under NICE TA875, where you pay the standard prescription charge in England, or nothing in Scotland, Wales and Northern Ireland. Privately, the price reflects the manufacturer's list price, the provider's clinical service, what follow-up and delivery are included, and the dose, including whether you move to the newer 7.2mg dose. This guide explains each factor so you can understand and compare costs. We do not quote prices here; see our prices page for current comparisons.

Why we don't quote prices

Wegovy is a prescription-only medicine (POM). Under UK law, set out in the Human Medicines Regulations and explained in the MHRA's Blue Guide on advertising and promotion, prescription-only medicines must not be advertised to the public. Publishing prices for a named prescription medicine can, in some contexts, amount to promotion.

Prices also change. Manufacturer list prices, wholesale costs and provider fees all move over time, and an article that quotes a figure can quickly mislead. Our prices page is updated separately and shows comparisons in a way that respects these rules. Medicine price details are shown there only where regulations allow; otherwise it compares services.

For an overview of the medicine itself, see the Wegovy hub and our complete guide to Wegovy in the UK.

NHS versus private: the two routes

See Wegovy on the NHS and private vs NHS weight loss treatment.

NHS prescription charges

In England, adults pay a fixed charge per prescription item unless they qualify for an exemption, for example because of age, certain medical conditions or low income. A prescription prepayment certificate can reduce costs for people who need several items regularly. Prescriptions are free in Scotland, Wales and Northern Ireland. Check the current charge and exemptions on the NHS website.

Why NHS access is limited

NICE recommended semaglutide within specialist weight management services partly because of cost-effectiveness and capacity. The two-year limit reflects the evidence available at the time of the appraisal. Access to these services varies across the country. Tirzepatide (Mounjaro) is being rolled out more widely in NHS primary care under NICE TA1026; see Mounjaro on the NHS.

What affects the private cost of Wegovy

1. The manufacturer's list price

Novo Nordisk sets a list price for Wegovy, which is the starting point for what pharmacies pay. Wholesale arrangements, discounts to pharmacies and supply conditions then affect what providers pay. When manufacturers change list prices, private prices usually follow. The September 2025 increase in the UK list price of Mounjaro, a competing medicine, is an example of how a list price change can affect the wider market. See the 2025 Mounjaro price rise.

2. The dose

Wegovy injections come in five strengths for the standard schedule (0.25mg to 2.4mg), plus the 7.2mg dose for some adults with obesity. Providers take different approaches:

• Flat pricing: the same charge for every strength.
• Tiered pricing: higher charges for higher strengths.
• Introductory pricing: a different charge for the first month or the starting dose. Look at the cost of the maintenance dose, which is what you are likely to pay for most of your treatment.

See Wegovy doses explained.

3. The 7.2mg dose and how it is supplied

The MHRA approved a 7.2mg weekly dose for adults with obesity in January 2026, based on the STEP UP trial. The UK leaflet initially described the dose as three 2.4mg injections given on the same day, which means using more medicine, and more pens, each month than at 2.4mg. A single-injection 7.2mg pen has since been reported as available. How the dose is supplied, and how a provider prices it, can make a significant difference to cost. Ask any provider how they supply and price 7.2mg before you consider it. Whether the higher dose is clinically appropriate is your prescriber's decision.

4. The provider's pricing model

Private providers use different structures, including:

• Per-order pricing: you pay for each pen or month of treatment as you order.
• Subscriptions: a recurring payment for regular supply, sometimes with a minimum term.
• Bundled programmes: medicine plus coaching, dietitian access or app-based support.
• Separate consultation fees: some charge for the initial consultation or reviews separately.

Check whether there is a minimum commitment, how cancellation works and whether prices are fixed for a period. Our guide to how weight loss injection pricing works explains these models in more detail.

5. What is included

Two prices that look similar can cover very different services. Check whether the cost includes:

• The initial consultation and identity and weight verification.
• Ongoing clinical reviews and dose changes.
• Access to a prescriber or pharmacist for questions and side effects.
• Needles and a sharps bin.
• Delivery, including temperature-controlled packaging.
• Additional support, such as nutrition advice.

See the hidden costs of private weight loss treatment.

6. Delivery and cold-chain handling

Wegovy pens should be stored in the fridge before first use. Regulated pharmacies send them in insulated packaging with cool packs. Some providers include delivery; others charge separately, sometimes with options for faster or timed delivery.

7. Supply and demand

Supply of GLP-1 medicines was tight in 2023 and 2024. Supply conditions, competition between providers and the arrival of new options, such as tablets and competing medicines, can all affect pricing.

8. How long you stay on treatment

The total cost of treatment depends heavily on duration. Trials such as STEP 4 and the STEP 1 extension showed that most people regain weight after stopping, which means many people consider treatment as long term. Before starting, it is worth thinking about the cost over a year or more, not just the first month. See the long-term cost of GLP-1 treatment.

How private providers build their prices

Understanding what sits behind a private price can make comparisons easier. A regulated provider's charge typically reflects several components:

• The medicine itself, based on the price the pharmacy pays its wholesaler, which is linked to the manufacturer's list price.
• Clinical time, including the prescriber who reviews your consultation and the pharmacist who checks and dispenses your prescription.
• Verification, such as identity checks and weight confirmation, which regulators expect for weight-loss medicines supplied online.
• Ongoing monitoring, including check-ins before dose increases and responses to side effect queries.
• Packaging and delivery, including insulated packaging and cool packs to keep pens within the right temperature range.
• Regulatory compliance, such as registration with the GPhC and, where relevant, the CQC, along with clinical governance and record keeping.
• Customer service and support programmes.

A lower price does not necessarily mean a worse service, and a higher price does not necessarily mean better care. Looking at what is included, and how the provider is regulated, helps you compare like with like.

When prices change during treatment

Private prices can change while you are on treatment, for example after a change in the manufacturer's list price. If this happens:

• Check your terms. Some providers fix prices for a period or give notice of changes.
• Do not stockpile. Ordering large quantities to avoid a price change can lead to pens expiring, being stored incorrectly, or being used without appropriate clinical review. Regulated providers may limit order quantities for safety reasons.
• Talk to your prescriber before changing medicine or dose because of cost. Switching medicine is a clinical decision.
• Avoid unregulated sources, however tempting the price.

Insurance and workplace schemes

Some people ask whether private medical insurance or workplace health schemes cover weight-loss medicines. Many policies exclude weight-loss treatment, or cover it only in specific circumstances, but terms vary. Check your policy documents or ask your insurer directly. Health cash plans and employee benefits schemes may offer support with some health costs; again, terms differ.

Cost-effectiveness: how NICE looks at price

When NICE appraises a medicine, it weighs the benefits against the cost to the NHS, usually measured in terms of quality-adjusted life years (QALYs). For semaglutide, NICE concluded in TA875 that it was cost-effective only within specialist weight management services, for a limited period. This explains why the NHS route is narrower than the licence. NICE assessments are made at the NHS price, which is typically different from private prices, and cost-effectiveness for the NHS is not the same as affordability for an individual.

Wegovy tablets and cost

The MHRA approved oral semaglutide for weight management, marketed as Wegovy tablets, in June 2026. The tablets are taken daily and follow their own dose schedule, rising to 25mg. Private pricing is still developing, and it is too early to say how it will compare with injections over time. NHS access requires a NICE recommendation, which had not been made at the time of writing.

Some people may prefer a tablet to an injection, but the tablet has its own requirements, such as taking it on an empty stomach and waiting before eating or drinking. Clinical suitability, side effects and personal preference matter alongside cost. See the oral semaglutide guide and tablets vs injections.

Comparing Wegovy with other options

The cost of Wegovy is often compared with Mounjaro (tirzepatide) and other medicines. When comparing, consider:

• Effectiveness: in SURMOUNT-5, tirzepatide produced greater average weight loss than semaglutide 2.4mg over 72 weeks. That trial did not include the 7.2mg dose.
• Tolerability: some people tolerate one medicine better than the other.
• Clinical factors: for people with established cardiovascular disease, the SELECT trial provides evidence for semaglutide 2.4mg specifically.
• NHS availability: routes differ between medicines.
• Pricing structures: these differ by medicine, dose and provider.

Choosing a medicine is a clinical decision for your prescriber; cost is one factor among several. See Mounjaro prices explained, Mounjaro vs Wegovy and our provider comparison.

Comparing providers like for like

Because providers package their services differently, a simple checklist can help you compare. The example below shows the kind of features worth recording for each provider you are considering. It does not describe any real provider.

Filling in a table like this for real providers, using the information on their websites or by asking them directly, gives a clearer picture of the total cost and the level of care than the headline figure alone. Our provider comparison and prices page collect much of this information in one place.

Costs beyond the medicine

Some costs sit outside what any provider charges:

• Scales and a tape measure for tracking progress.
• Changes to food shopping, such as more protein-rich foods, which can cost more or less than your previous diet.
• Clothing, as your size changes.
• Gym membership or exercise classes, if you choose them.
• Time off work for NHS appointments, if you are treated in a specialist service.

These are not reasons to avoid treatment, but they are part of a realistic picture of what it involves.

Warning signs of unsafe offers

The MHRA has repeatedly warned about falsified and unlicensed weight-loss injections sold online, on social media and through messaging apps. Warning signs include:

• No consultation, or only a brief questionnaire with no verification.
• No requirement to confirm your identity or weight.
• Prices far below those of regulated UK providers.
• Pens or vials that look different from the official product, or labelled "for research use only".
• Sellers on social media, beauty salons or gyms.
• No UK pharmacy registration details.
• Pressure to act quickly, or promises of specific results.

A legitimate UK provider will have a registered pharmacy listed with the General Pharmaceutical Council (GPhC), and online services providing prescribing should be regulated by the appropriate body, such as the Care Quality Commission (CQC) in England. See fake and unlicensed weight-loss jabs, who regulates online weight loss services and how to choose an online pharmacy.

Questions to ask before you start

1. What is the cost at each dose, and at the maintenance dose in particular?
2. How do you supply and price the 7.2mg dose, if it becomes appropriate?
3. What is included: consultations, reviews, needles, delivery, support?
4. Is there a minimum term or cancellation fee?
5. How often do prices change, and how will I be told?
6. How do I contact a clinician about side effects or dose changes?
7. What happens if I need to pause or stop treatment?

Budgeting for treatment

• Plan for the long term. Consider what you could sustain over a year or more, given that stopping often leads to weight regain.
• Look at the total, not the introductory price.
• Factor in extras, such as scales, any supplements recommended by a clinician, or changes to food shopping.
• Avoid running out. Gaps in treatment can mean restarting at a lower dose and repeating side effects. Order in good time.
• Do not split or share pens, or stretch doses to save money. This is unsafe and not in line with the licence.

If cost becomes a barrier, discuss options with your prescriber or GP, including whether you might be eligible for NHS treatment.

When to speak to a professional

Speak to your GP if you think you may be eligible for NHS treatment. They can advise whether referral to a specialist weight management service, or another NHS option, may be possible.

Speak to your prescriber before:

• Changing your dose, pausing or stopping treatment for cost reasons.
• Switching between Wegovy, Mounjaro or tablets.
• Moving to the 7.2mg dose.

Never use Wegovy obtained without a prescription, or from an unregulated source.

Seek urgent medical help (NHS 111, or 999 / A&E in an emergency) if, while taking Wegovy, you develop:

• Severe, persistent abdominal pain, which may spread to your back, with or without vomiting.
• Signs of severe dehydration, such as confusion or passing very little urine.
• Signs of a serious allergic reaction, such as swelling of the face or throat, or difficulty breathing.

If you think you have received a fake or suspicious product, do not use it. Report it to the MHRA through the Yellow Card scheme and speak to a pharmacist.

Decisions about whether Wegovy is right for you, at which dose and for how long, belong to your prescriber.